Experimental Veliparib Improves Outcomes for Adv BRCA+ HER2-

Options
Moderators
Moderators Member Posts: 25,912
edited June 2020 in Stage IV/Metastatic Breast Cancer ONLY

Have you been diagnosed with advanced-stage HER2-negative breast cancer, but haven't had genetic testing? A study underscores how PARP inhibitors can help treat this type of cancer in people with a BRCA1 or BRCA2 mutation, so it makes sense to talk to your doctor about genetic testing.

Read: Experimental Veliparib Improves Outcomes for People With BRCA Mutation and Advanced-Stage HER2-Negative Breast Cancer

· Share on FacebookShare on Twitter

Comments

  • Bestbird
    Bestbird Member Posts: 2,818
    edited June 2020

    Mods, why would you recommend an experimental therapy for BRCA+, HER2- MBC patients when there are 2 approved targeted treatments, namely Olaparib and Talazoparib?

    · Share on FacebookShare on Twitter
  • Moderators
    Moderators Member Posts: 25,912
    edited June 2020

    Bestbird -- thank you for your feedback. We are not recommending any treatment; we are simply sharing a new Research News article with the Community. We always encourage our members to talk to their doctors about any new treatments and if it would make sense for their unique situation.

    --The Mods

    · Share on FacebookShare on Twitter

Categories